Secondary outcomes included the risks of specific cancers in the tirzepatide group versus the control groups
New patients still titrating through starting doses should not prepay, because dose adjustments might require switching products or providers
Unfortunately, compared to tumor cells, immune cells have difficulty adapting to the constantly evolving tumor through "microevolution" because the latter develops new immune escape mechanisms [150]
Companies are investing heavily in R&D to develop bioavailable, non-irritant formulations that meet regulatory standards, further expanding market opportunities
Hoffman, A cohort study of acute pancreatitis in relation to exenatide use , Diabetes, Obesity and Metabolism , vol
The vigorous agitation creates shear forces that denature the peptide by breaking its molecular bonds